2014至2016年法国HIV-1原发感染监测:耐药稳定但多样性、聚集性和毒力更高?
该研究纳入2014至2016年法国1121例HIV-1原发感染患者,分析传播性耐药相关突变(TDRAM)、病毒亚型及近期传播聚集。结果显示TDRAM总体为10.8%,自2007年以来保持稳定;非B亚型增多,CRF02_AG毒株病毒载量更高,并发现138个近期传播聚集。
要点
- 法国原发感染患者TDRAM总体10.8%,含依曲韦林和利匹韦林相关突变为18.6%。
- CRF02_AG病毒载量高于B亚型(5.83 vs 5.40 log10 copies/mL,P=0.004)。
- 发现138个近期传播聚集,占总体41%,提示需实时聚集识别以指导预防。
核心结论
- 自2007年以来法国原发感染患者中TDRAM比例保持稳定,但非B亚型增多且CRF02_AG可能毒力更强。
- 大型近期传播聚集的存在提示需实时识别传播簇以采取针对性预防措施控制疫情。
研究设计与样本
- 研究纳入2014至2016年法国1121例HIV-1原发感染患者,使用2009 Stanford列表和法国ANRS算法鉴定TDRAM,并分析病毒亚型和近期传播聚集。
主要发现
- 患者主要为MSM(70%)和居住于巴黎地区(42%)。
- TDRAM总体为10.8%,包含依曲韦林和利匹韦林相关TDRAM时升至18.6%。
- PI、NRTI、第一代NNRTI、第二代NNRTI和整合酶抑制剂相关TDRAM的流行率分别为2.9%、5.0%、4.0%、9.4%和5.4%。
- 多变量分析中,年龄>40岁和非R5嗜性病毒与TDRAM风险增加>2倍相关。
- B亚型和CRF02_AG为主要谱系(分别56%和20%),CRF02_AG病毒载量高于B亚型(5.83 vs 5.40 log10 copies/mL,P=0.004)。
临床怎么用
- 对原发感染患者应关注TDRAM检测,尤其年龄>40岁或非R5嗜性病毒者风险更高。
- CRF02_AG感染可能伴随更高病毒载量,临床需留意疾病进展风险。
- 利用近期传播聚集信息可指导针对性预防干预以控制HIV传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with primary HIV-1 infection (PHI) are a particular population, giving important insight about ongoing evolution of transmitted drug resistance-associated mutation (TDRAM) prevalence, HIV diversity and clustering patterns. We describe these evolutions of PHI patients diagnosed in France from 2014 to 2016. METHODS: A total of 1121 PHI patients were included. TDRAMs were characterized using the 2009 Stanford list and the French ANRS algorithm. Viral subtypes and recent transmission clusters (RTCs) were also determined. RESULTS: Patients were mainly MSM (70%) living in the Paris area (42%). TDRAMs were identified among 10.8% of patients and rose to 18.6% when including etravirine and rilpivirine TDRAMs. Prevalences of PI-, NRTI-, first-generation NNRTI-, second-generation NNRTI- and integrase inhibitor-associated TDRAMs were 2.9%, 5.0%, 4.0%, 9.4% and 5.4%, respectively. In a multivariable analysis, age >40 years and non-R5 tropic viruses were associated with a >2-fold increased risk of TDRAMs. Regarding HIV diversity, subtype B and CRF02_AG (where CRF stands for circulating recombinant form) were the two main lineages (56% and 20%, respectively). CRF02_AG was associated with higher viral load than subtype B (5.83 versus 5.40 log10 copies/mL, P=0.004). We identified 138 RTCs ranging from 2 to 14 patients and including overall 41% from the global population. Patients in RTCs were younger, more frequently born in France and more frequently MSM. CONCLUSIONS: Since 2007, the proportion of TDRAMs has been stable among French PHI patients. Non-B lineages are increasing and may be associated with more virulent CRF02_AG strains. The presence of large RTCs highlights the need for real-time cluster identification to trigger specific prevention action to achieve better control of the epidemic.
引用
- Visseaux B, Assoumou L, Mahjoub N, et al. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence? J Antimicrob Chemother. 2020. PMID: 31641777. doi:10.1093/jac/dkz404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。